• 1
    Wallace MS, Zawie DA, Garvey MS. Gastric ulceration in the dog secondary to the use of nonsteroidal antiinflammatory drugs. J Am Anim Hosp Assoc 1990; 26:467472.
  • 2
    Stanton ME, Bright RM. Gastroduodenal ulceration in dogs: Retrospective study of 43 cases and literature review. J Vet Int Med 1989;3:238244.
  • 3
    Boulay JP, Lipowitz AJ, Klausner JS. Effect of cimetidine on aspirin-induced gastric hemorrhage in dogs. Am J Vet Res 1986;47: 17441746.
  • 4
    Konturek SJ, Piastucki I., Brzozowski T., et al. Role of prostaglandins in the formation of aspirin-induced ulcers. Gastroenterology 1981; 80:49.
  • 5
    Lipowitz AJ, Boulay JP, Klausner JS. Serum salicylate concentrations and endoscopic evaluation of the gastric mucosa in dogs after oral administration of aspirin-containing products. Am J Vet Res 1986;47:15861589.
  • 6
    Soll AH, Kurata J, McGuigan. Ulcers, nonsteroidal antiinflammatory drugs, and related matters. Gastroenterology 1989; 96: 561568.
  • 7
    Graham DY. Prevention of gastroduodenal injury by chronic nonsteroidal antiinflammatory drug therapy. Gastroenterology 1989; 96:675681.
  • 8
    Graham DY, Smith JL. Gastroduodenal complications of chronic NSAID therapy. Am J Gastroenterol 1988;83:10811084.
  • 9
    Kauffman G. Aspirin-induced gastric mucosa injury: Lessons learned from animal models. Gastroenterology 1989; 96:606614.
  • 10
    Jones JB, Bailey RT. Misoprostol: A prostaglandin E, analog with antisecretory and cytoprotective properties. Ann Pharmacotherap 1989; 23:276282.
  • 11
    Jiranek GC, Kimmey MB, Saunders DR, et al. Misoprostol reduces gastroduodenal injury from one week of aspirin: An endoscopic study. Gastroenterology 1989; 96:656661.
  • 12
    Roth S., Agrawal N., Mahowald M., et al. Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin. Arch Intern Med 1989; 149:775779.
  • 13
    Bauer RF. Misoprostol preclinical pharmacology. Dig Dis Sci 1985;30:118S125S (suppl).
  • 14
    Goodlad RA, Madgwick AJ, Moffat MR, et al. Effects of misoprostol on cell migration and transit in the dog stomach. Gastroenterology 1990; 98:9095.
  • 15
    Staumont G., Fioramonti J., Frexinos J., et al. Oral prostaglandin E analogues induce intestinal migrating motor complexes after a meal in dogs: Evidence for a central mechanism. Gastroenterology 1990;98:888893.
  • 16
    Henagan JM, Schmict KL, Miller TA. Prostaglandin prevents aspirin injury in the canine stomach under in vivo but not in vitro conditions. Gastroenterology 1989; 97:649659.
  • 17
    Schoenhard G., Opperman J., Kohn FE. Metabolism and pharmacokinetic studies of misoprostol. Dig Dis Sci 1985;30:126S128S (suppl).
  • 18
    Goodlad RA, Madgwick AJ, Moffatt MR, et al. Prostaglandins and the dog stomach: Effects of misoprostol on the proportion of mucosa to muscle and on the proportion of different epithelial cell types. Digestion 1990;45:212216.
  • 19
    Gullikson GW, Anglin CP, Kessler LK, et al. Misoprostol attenuates aspirin-induced changes in potential difference and associated damage in canine gastric mucosa. Clinical Inv Med 1987; 10: 145151.
  • 20
    Murtaugh RJ, Matz ME, Labato MA, Boudrieau RJ. Use of synthetic prostaglandin E, (misoprostol) administration for prevention of aspirin induced gastroduodenal ulceration in arthritic dogs. J Am Vet Med Assoc 1993;202:251256.
  • 21
    PROC ANOVA. SAS/STAT User's Guide. Volume 1, 4th ed. SAS Institute Inc., Cory , NC , 1990;209244.
  • 22
    Roth L., Leib MS, Davenport DJ, et al. Comparisons between endoscopic and histologic evaluation of the gastrointestinal tract in dogs and cats: 75 cases (1984–1987). J Am Vet Med Assoc 1990; 196:635638.
  • 23
    SAS/STAT User's Guide. Volume 1, 4th ed. SAS Institute Inc., Cory , NC , 1990; 130132.
  • 24
    Conner WJ. Practical nonparametric statistics. 2nd ed. New York , NY : John Wiley & Sons; 1971:229231.
  • 25
    Stat Xact. Cytel software corporation. Cambridge , MA . 1992.
  • 26
    SAS/STAT User's Guide. Volume 2, 4th ed. SAS Institute Inc., Cory , NC , 1990; 16331640.
  • 27
    Miller TA. Gastroduodenal mucosal defense: Factors responsible for the ability of the stomach and duodenum to resist injury. Surgery 1988; 103:389397.
  • 28
    Whittle BJR, Vane JR. Prostanoids as regulators of gastrointestinal function. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract, Vol 1, 2nd ed. New York , NY : Raven Press; 1987:143180.
  • 29
    Kuo Y., Shanbour LL. Mechanism of action of aspirin on canine gastric mucosa. Am J Physio 1976; 230:762767.
  • 30
    Tsai BS, Kessler LK, Collins P., et al. Antisecretory activity of misoprostol, its racemates, stereoisomers and metabolites in isolated parietal cells. Prostaglandins 1987;33:3039 (suppl).
  • 31
    Lanza FL, Aspinall RL, Swabb EA, et al. Double-blind, placebo-controlled endoscopic comparison of the mucosal effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Gastroenterology 1988; 95:289294.
  • 32
    McCarthy DM. Nonsteroidal antiinflammatory drug-induced ulcers: Management by traditional therapies. Gastroenterology 1989;96:662674.
  • 33
    Lanza FL, Fakouhi D., Rubin A., et al. Double-blind placebocontrolled comparison of the efficacy and safety of 50, 100, and 200 μg of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms. Am J Gastroenterol 1989; 84:633636.
  • 34
    Lanza FL, Kochman RL, Geis GS, et al. A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits. Am J Gastroenterol 1991; 86:17431748.
  • 35
    Collins LG, Tyler DE. Experimentally induced phenylbutazone toxicosis in ponies: description of the syndrome and the prevention with synthetic prostaglandin E2. Am J Vet Res 1985;46: 16051615.
  • 36
    Graham DY, Smith JL, Spjut HJ, et al. Gastric adaptation: studies in humans during continuous aspirin administration. Gastroenterology 1988;95:327333.